Pharmaceutical microbiology is a specialized field within the pharmaceutical industry that focuses on the study of microorganisms and their impact on the production and quality of pharmaceutical products. Microorganisms, such as bacteria, fungi, viruses, and parasites, can pose significant challenges to the manufacturing process and the safety of pharmaceuticals.
One critical aspect of pharmaceutical microbiology is ensuring the sterility of pharmaceutical products, especially injectable medications and other sterile formulations. Microbial limits testing is essential procedure that establishes the acceptable levels of microbial contamination in non-sterile pharmaceuticals.
In addition to quality control measures, pharmaceutical microbiologists play a crucial role in monitoring and maintaining the cleanliness of manufacturing facilities. Environmental monitoring involves regularly testing the air, surfaces, and personnel for microbial contamination to prevent the introduction of harmful microorganisms during the production process.
The field of pharmaceutical microbiology is dynamic, evolving to address emerging challenges such as antimicrobial resistance and the development of microbiome-based therapies. By integrating microbiological principles into pharmaceutical practices, this discipline ensures the production of safe and effective medications for global healthcare.
Title : Ectopically expressed olfactory receptors as an untapped family of drug targets and discovery of agonists and antagonists of OR51E1, an understudied G protein-coupled receptor
Vladlen Slepak, University of Miami Miller School of Medicine, United States
Title : Managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Analytical strategies for solid-state forms in drug development
Maria Cristina Gamberini, University of Modena e Reggio Emilia, Italy
Title : Understanding drug transport in plasma: The role of protein binding
Saad Tayyab, UCSI University, Malaysia
Title : Innovative development and delivery of biologics for chronic obstructive pulmonary disease
Yong Xiao Wang, Albany Medical College, United States
Title : Search for novel biomarkers and therapeutic targets for inflammatory disease
Madhav Bhatia, University of Otago, New Zealand
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model through de-sign-inspired biotech- & biopharma-driven applications and upgraded business mar-keting to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Design and evaluation of exo-itc: A bilayer fibrous system for controlled exosome delivery in dermatological applications
Luis Jesus Villarreal Gomez, FCITEC - Universidad AutĂłnoma de Baja California, Mexico
Title : Abuse-deterrent dosage form technique utilizing a fusion of innovative pharmaceuticals and ion exchange resin
Bhupendra Gopalbhai Prajapati, Parul University, India
Title : Macitentan/tadalafil combination– An additional value in pharmacotherapy of pulmonary arterial hypertension
Miroslav Radenkovic, University of Belgrade, Serbia